Illumina, Inc. (ILMN)
269.42
+0.02
(+0.01%)
USD |
NASDAQ |
Oct 23, 16:00
267.60
-1.82
(-0.68%)
After-Hours: 20:00
Illumina Enterprise Value : 42.04B for Oct. 23, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 42.04B |
| October 22, 2026 | 42.04B |
| October 21, 2026 | 44.07B |
| October 20, 2026 | 41.82B |
| October 19, 2026 | 41.02B |
| October 16, 2026 | 41.00B |
| October 15, 2026 | 41.82B |
| October 14, 2026 | 42.39B |
| October 13, 2026 | 42.31B |
| October 12, 2026 | 43.14B |
| October 09, 2026 | 43.36B |
| October 08, 2026 | 41.31B |
| October 07, 2026 | 41.79B |
| October 06, 2026 | 42.66B |
| October 05, 2026 | 45.71B |
| October 02, 2026 | 42.59B |
| October 01, 2026 | 41.48B |
| September 30, 2026 | 42.68B |
| September 29, 2026 | 42.43B |
| September 28, 2026 | 42.42B |
| September 25, 2026 | 42.13B |
| September 24, 2026 | 42.72B |
| September 23, 2026 | 39.92B |
| September 22, 2026 | 38.73B |
| September 21, 2026 | 37.42B |
| Date | Value |
|---|---|
| September 18, 2026 | 37.54B |
| September 17, 2026 | 38.38B |
| September 16, 2026 | 35.93B |
| September 15, 2026 | 34.92B |
| September 14, 2026 | 32.80B |
| September 11, 2026 | 32.53B |
| September 10, 2026 | 31.75B |
| September 09, 2026 | 32.31B |
| September 08, 2026 | 33.23B |
| September 04, 2026 | 34.31B |
| September 03, 2026 | 34.83B |
| September 02, 2026 | 33.56B |
| September 01, 2026 | 32.64B |
| August 31, 2026 | 33.62B |
| August 28, 2026 | 33.91B |
| August 27, 2026 | 35.74B |
| August 26, 2026 | 35.31B |
| August 25, 2026 | 35.33B |
| August 24, 2026 | 35.07B |
| August 21, 2026 | 34.49B |
| August 20, 2026 | 33.56B |
| August 19, 2026 | 32.31B |
| August 18, 2026 | 29.79B |
| August 17, 2026 | 30.52B |
| August 14, 2026 | 30.18B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Thermo Fisher Scientific, Inc. | 284.58B |
| Agilent Technologies, Inc. | 50.99B |
| Pacific Biosciences of California, Inc. | 1.125B |
| Danaher Corp. | 184.25B |
| Bio-Rad Laboratories, Inc. | 9.642B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 207.00M |
| Revenue (Quarterly) | 1.161B |
| Total Expenses (Quarterly) | 954.00M |
| EPS Diluted (Quarterly) | 1.353 |
| Gross Profit Margin (Quarterly) | 66.49% |
| Profit Margin (Quarterly) | 17.83% |
| Earnings Yield | 1.99% |
| Operating Earnings Yield | 2.16% |
| Normalized Earnings Yield | 1.742 |